tiprankstipranks
Trending News
More News >

Damayanti Kerai Profile - HSBC Analyst

4 Followers
tipranks
Damayanti Kerai

Damayanti Kerai
HSBC

Wall Street Analyst
#5,256 out of 9,888 Wall Street Analysts
#14,158 out of 41,493 experts

Success Rate

34%
12 out of 35 ratings made a profit

Average Return

+2.10%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Damayanti Kerai's trades since 2025 and holding each position for 1 Year would result in 34.29% of your transactions generating a profit, with an average return of 2.1% per rating.

Stock Rating Distribution

52Ratings
57.69% Buy
28.85% Hold
13.46% Sell
Distribution of Damayanti Kerai's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Glenmark Pharmaceuticals Limited
(GLENMARK)
Rating:Buy
Date:May 27, 2025 - Today
Return:+60.80%
The most profitable rating made by Damayanti Kerai

Damayanti Kerai's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Lupin Limited
May 16, 2025
Buy
Reiterated
₹2,300.00
(19.04%Upside)
3Ratings
0%
-4.50%
Aurobindo Pharma Ltd
May 28, 2025
Buy
Reiterated
₹1,415.00
(24.18%Upside)
2Ratings
50%
-1.65%
Dr. Reddy's Laboratories Ltd.
Jun 04, 2025
Buy
Upgraded
₹1,445.00
(14.91%Upside)
2Ratings
100%
+1.50%
Dr Reddy's Laboratories
Jun 05, 2025
Buy
Upgraded
$16.90
(16.71%Upside)
1Ratings
0%
-5.40%
Apollo Hospitals Enterprise Limited
Jul 02, 2025
Buy
Reiterated
₹8,435.00
(15.49%Upside)
1Ratings
0%
-1.30%
Divi's Laboratories Limited
Jul 08, 2025
Buy
Upgraded
₹7,900.00
(17.36%Upside)
2Ratings
0%
-7.90%
Alkem Laboratories Ltd.
Jul 17, 2025
Hold
Reiterated
₹4,825.00
(-3.47%Downside)
3Ratings
0.00%
Alembic Pharmaceuticals Limited
Jul 17, 2025
Hold
Reiterated
₹945.00
(-8.38%Downside)
2Ratings
0.00%
Aster DM Healthcare Ltd.
Jul 17, 2025
Buy
Reiterated
₹660.00
(10.99%Upside)
1Ratings
0%
0.00%
Biocon Limited
Jul 17, 2025
Buy
Reiterated
₹425.00
(6.54%Upside)
4Ratings
75%
+9.58%
List of latest recommendations made by Damayanti Kerai. Click to expand and see Damayanti Kerai's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

Damayanti Kerai activity FAQ

What is the performance of Damayanti Kerai's recommendations?
The percentage of profitable recommendations made by Damayanti Kerai is 34%, and the average return per transaction is 2.10%.
    What stocks does Damayanti Kerai cover?
    Damayanti Kerai mostly covers IN:GLENMARK , IN:BIOCON , IN:CIPLA stocks.
      What was Damayanti Kerai's most profitable rating?
      Damayanti Kerai’s most profitable ratings was a buy on IN:GLENMARK stock on May 27, 2025 - Today. The return on the trade was +60.80%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here